CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's Revenue Growth by Quarter and Year

Mateon Therapeutics Inc's Revenue results by quarter and year




OXGN Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - - - -
III Quarter September 0.00 - - -
II Quarter June 1.40 - - -
I Quarter March 0.34 - - -
FY   1.74 - - -



OXGN Revenue third quarter 2020 Y/Y Growth Comment
Mateon Therapeutics Inc in the third quarter recorded of $ 0.00 millions.

According to the results reported in the third quarter, Mateon Therapeutics Inc achieved the best Revenue growth in Biotechnology & Drugs industry. While Mateon Therapeutics Inc' s Revenue no change of % ranks overall at the positon no. in the third quarter.




OXGN Revenue ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's third quarter 2020 Revenue $ 0.00 millions OXGN's Income Statement
Mateon Therapeutics Inc's third quarter 2019 Revenue $ 0.00 millions Quarterly OXGN's Income Statement
New: More OXGN's historic Revenue Growth >>


OXGN Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June 311.76 % - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mateon Therapeutics Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
310.73 % -17.85 % -100 %
(Jun 30 2020)   (Sep 30 2020)


OXGN's III. Quarter Q/Q Revenue Comment
III. Quarter 2020 of 0.00 millions by Mateon Therapeutics Inc come out even worse if you take a look at 1.40 millions a quarter before.

Within Biotechnology & Drugs industry 140 other companies have achieved higher Revenue quarter on quarter growth. While Mateon Therapeutics Inc's Revenue growth quarter on quarter, overall rank is 3856.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #141
Healthcare Sector #617
Overall #3856
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #141
Healthcare Sector #617
Overall #3856
Revenue Q/Q Growth Statistics
High Average Low
310.73 % -17.85 % -100 %
(Jun 30 2020)   (Sep 30 2020)


OXGN's III. Quarter Q/Q Revenue Comment
Current accomplishment of 0.00 millions by Mateon Therapeutics Inc appear even more unfavourable if you take a look at 1.40 millions in the second quarter.

Within Biotechnology & Drugs industry 140 other companies have achieved higher Revenue quarter on quarter growth. While Mateon Therapeutics Inc's Revenue growth quarter on quarter, overall rank is 3856.


Mateon Therapeutics Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Sep 30 2020 period, Mateon Therapeutics Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Sep 30 2020 period, Mateon Therapeutics Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OXGN's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for OXGN's Competitors
Revenue Growth for Mateon Therapeutics Inc's Suppliers
Revenue Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2020
Ensign Group Inc -0.21 %$ -0.208 millions
Crh Medical Corporation -0.21 %$ -0.215 millions
Radnet Inc -0.24 %$ -0.237 millions
Tenet Healthcare Corp -0.24 %$ -0.241 millions
Prestige Consumer Healthcare Inc -0.27 %$ -0.272 millions
Establishment Labs Holdings Inc -0.42 %$ -0.420 millions
Cocrystal Pharma Inc -0.61 %$ -0.610 millions
Rockwell Medical inc -0.83 %$ -0.826 millions
Tactile Systems Technology Inc -1.05 %$ -1.048 millions
Regional Health Properties Inc -1.30 %$ -1.304 millions
American Bio Medica Corp -1.34 %$ -1.341 millions
Transmedics Group Inc -1.58 %$ -1.582 millions
Boston Scientific Corporation -1.77 %$ -1.773 millions
Bruker Corporation -1.86 %$ -1.861 millions
Amyris Inc -1.99 %$ -1.988 millions
Orthofix Medical Inc -2.21 %$ -2.215 millions
Encision Inc -2.29 %$ -2.288 millions
Integra Lifesciences Holdings Corp -2.34 %$ -2.338 millions
Neurometrix Inc -2.48 %$ -2.480 millions
Lifevantage Corp -2.49 %$ -2.492 millions
Macrogenics Inc -2.60 %$ -2.604 millions
Bionexus Gene Lab Corp -2.90 %$ -2.904 millions
Alimera Sciences Inc -2.93 %$ -2.934 millions
Fortress Biotech Inc -3.04 %$ -3.039 millions
Teleflex Incorporated -3.09 %$ -3.088 millions
Bausch Health Companies Inc -3.21 %$ -3.214 millions
Atricure Inc -3.28 %$ -3.280 millions
Electromed Inc -3.59 %$ -3.593 millions
Community Health Systems Inc -3.70 %$ -3.697 millions
Curis Inc -3.99 %$ -3.992 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ARWR's Profile

Stock Price

ARWR's Financials

Business Description

Fundamentals

Charts & Quotes

ARWR's News

Suppliers

ARWR's Competitors

Customers & Markets

Economic Indicators

ARWR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071